Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Support or don't
  • the Swartz Financing
  • the Master Agreement
  • the Dividends
  • the Dividends payable to warrant holders
  • .

    Ok, pray tell, given the condition of PTSC at the time of the above, what you would have done differently, with the information available at the respective junctures.

    Should you believe that financing would have been available to PTSC, with ever-increasing losses, from mainstream financiers, please disregard my above request.

    .

    .

    .

    Be well

    Share
    New Message
    Please login to post a reply